age1 VC x Stanford Biotech Group Mixer
Curious about biotech venture capital? Want to learn more about the process of ideating and building therapeutics companies focused on age-related diseases?
Join the Stanford Biotechnology Group for a panel and mixer with age1 VC, the first biotech VC focused on extending healthy lifespan and combatting age-related diseases. age1 specializes in early-stage investing and company creation, backing companies like Until Labs, Loyal, Gordian, Aerska, Science Corp, and NewLimit.
Hear from Madi Ueland (senior associate at age1, Stanford '23), Lada Nuzhna (founder/CEO of age1 portfolio company General Control), Doug Henze (venture fellow at age1, Stanford PhD candidate in Quake Lab) and Satvik Dasariraju (partner at age1, advisory board chair of the Aging Initiative) about the bleeding-edge of longevity science, combining pragmatism and ambition in generating therapeutic concepts, and community building in the biotech world. age1's investment team is hiring summer interns and fellows, and the firm is also recruiting across its portfolio; General Control is hiring computational scientists, a scientific chief of staff, and summer interns.
Come learn about how to apply for positions at age1 and General Control + enjoy food and drinks!
Date: December 7th, 2026
Time: 5 to 7pm Pacific
Location: Bass Biology 122
RSVP: https://luma.com/c2e49kqp
